Resultados de la búsqueda 301-310 of 8868 for Assay

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  4. Medicina cardiovascular - Ensayos clínicos

    Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

  5. Medicina cardiovascular - Ensayos clínicos

    Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  7. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

  8. Mayo Clinic Physician Update - July 2024

    Page 1.

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...